What the business is, and whether it's a good one at a fair price.
Operates diagnostic centres and laboratories offering pathology and imaging services, including SPECT and SPECT-CT scans, with facilities in Delhi and Gurugram. Revenue of Rs 83.11 crore in FY26 grew 6.6% from FY25, though profit after tax declined to Rs 525.33 Lacs from Rs 900.79 Lacs. The company listed on the BSE SME platform in January 2026 after raising Rs 36.89 crore through an IPO, with proceeds primarily intended for medical equipment purchases and working capital. In March 2026, it upgraded imaging equipment at its Gurugram Sector-40 centre from SPECT to SPECT-CT, and is revising the location for a new laboratory within Delhi. Employee costs account for 27.6% of revenue and other operating expenses for 31.2%. Total assets reached Rs 118.60 crore by FY26 year-end, nearly double the prior year, supported by IPO proceeds and increased borrowings.
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
Not enough history to assess.How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from MODERN DIAGNOSTIC & RESEARCH C's filed financials and exchange disclosures
MODERN DIAGNOSTIC & RESEARCH C is a Healthcare Services company listed on BSE.
Effectively yes. It holds ₹9 Cr more cash than debt.
On trailing P/E, MODERN DIAGNOSTIC & RESEARCH C ranks 22 of 29 in Healthcare Service Provider — cheaper than 25% of them, against an industry median of 23.2×. This is a position, not a valuation judgement.
On a typical session MODERN DIAGNOSTIC & RESEARCH C moves 2.60% — that is the median absolute close-to-close move across its last 140 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by MODERN DIAGNOSTIC & RESEARCH C appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.